Germline BRCA Mutation and Clinical Outcomes in Breast Cancer Patients Focusing on Survival and Failure Patterns: A Long-Term Follow-Up Study of Koreans

Germline breast cancer susceptibility gene mutations and breast cancer outcomes

(2018) Yong Alison Wang et al.   BMC CANCER

Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study

(2018) Ellen R Copson et al.   LANCET ONCOLOGY

Clinical outcomes according to molecular subtypes in stage II-III breast cancer patients treated with neoadjuvant chemotherapy followed by surgery and radiotherapy

(2016) Hakyoung Kim et al.   Asia-Pacific Journal of Clinical Oncology

Ten-Year Survival in Patients With BRCA1-Negative and BRCA1-Positive Breast Cancer

(2013) Tomasz Huzarski et al.   JOURNAL OF CLINICAL ONCOLOGY

BRCA Mutation Testing in Determining Breast Cancer Therapy

(2011) Karen Lisa Smith et al.   CANCER JOURNAL

Population-Based Study of the Risk of Second Primary Contralateral Breast Cancer Associated With Carrying a Mutation inBRCA1orBRCA2

(2010) Kathleen E. Malone et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognosis of BRCA-associated breast cancer: a summary of evidence

(2009) L. Bordeleau et al.   BREAST CANCER RESEARCH AND TREATMENT

Is the breast-conserving treatment with radiotherapy appropriate in BRCA1/2 mutation carriers? Long-term results and review of the literature

(2009) Youlia M. Kirova et al.   BREAST CANCER RESEARCH AND TREATMENT